Papaya

Bitki adı: Papaya, fruit, leaves
Bilimsel adı: Carica papaya
Cins: Carica
Familya: Caricaceae
Diğer adları: Papaya

Carica papaya

Genel Bilgiler


Duke – Ethnobotany

Bilgi: Duke USEAGE: F | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb24: 356
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb28: 10
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb25: 365
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb30: 133
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Takeda
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb25: 365
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb25: 364
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb30: 133
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb30: 133
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Gupta
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Bliss
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Gupta
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb25: 364
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb30: 133
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb25: 365
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Gupta
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Standley
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Takeda
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb30: 133
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb30: 133
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb29: 286
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Gupta
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Gupta
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Bliss
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Ayensu
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb30: 133
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Standley
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Brutus
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb30: 133
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Woi.Syria
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb25: 364
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Bliss
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Gupta
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb30: 133
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Wong
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Liogier
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Burkill,1966
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Gupta
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Eb28: 10
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Martinez
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Steinmetz
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Hartwell
Kaynak: James A. Duke
Bilgi: Duke USEAGE: F | Duke,1972
Kaynak: James A. Duke

Bilimsel Araştırmalar

Reactive oxygen and nitrogen species (RONS) are produced by several endogenous and exogenous processes, and their negative effects are neutralized by antioxidant defenses. Oxidative stress occurs from the imbalance between RONS production and these antioxidant defenses. Aging is a process characterized by the progressive loss of tissue and organ function. The oxidative stress theory of aging is based on the hypothesis that age-associated functional losses are due to the accumulation of RONS-induced damages. At the same time, oxidative stress is involved in several age-related conditions (ie, cardiovascular diseases [CVDs], chronic obstructive pulmonary disease, chronic kidney disease, neurodegenerative diseases, and cancer), including sarcopenia and frailty. Different types of oxidative stress biomarkers have been identified and may provide important information about the efficacy of the treatment, guiding the selection of the most effective drugs/dose regimens for patients and, if particularly relevant from a pathophysiological point of view, acting on a specific therapeutic target. Given the important role of oxidative stress in the pathogenesis of many clinical conditions and aging, antioxidant therapy could positively affect the natural history of several diseases, but further investigation is needed to evaluate the real efficacy of these therapeutic interventions. The purpose of this paper is to provide a review of literature on this complex topic of ever increasing interest.

Makaleyi görüntüle
Chloroplasts play a crucial role in sustaining life on earth. The availability of over 800 sequenced chloroplast genomes from a variety of land plants has enhanced our understanding of chloroplast biology, intracellular gene transfer, conservation, diversity, and the genetic basis by which chloroplast transgenes can be engineered to enhance plant agronomic traits or to produce high-value agricultural or biomedical products. In this review, we discuss the impact of chloroplast genome sequences on understanding the origins of economically important cultivated species and changes that have taken place during domestication. We also discuss the potential biotechnological applications of chloroplast genomes.

Makaleyi görüntüle
The number of sequenced plant genomes and associated genomic resources is growing rapidly with the advent of both an increased focus on plant genomics from funding agencies, and the application of inexpensive next generation sequencing. To interact with this increasing body of data, we have developed Phytozome (http://www.phytozome.net), a comparative hub for plant genome and gene family data and analysis. Phytozome provides a view of the evolutionary history of every plant gene at the level of sequence, gene structure, gene family and genome organization, while at the same time providing access to the sequences and functional annotations of a growing number (currently 25) of complete plant genomes, including all the land plants and selected algae sequenced at the Joint Genome Institute, as well as selected species sequenced elsewhere. Through a comprehensive plant genome database and web portal, these data and analyses are available to the broader plant science research community, providing powerful comparative genomics tools that help to link model systems with other plants of economic and ecological importance.

Makaleyi görüntüle
It is more than 50 years since the lysosome was discovered. Since then its hydrolytic machinery, including proteases and other hydrolases, has been fairly well identified and characterized. Among these are the cysteine cathepsins, members of the family of papain-like cysteine proteases. They have unique reactive-site properties and an uneven tissue-specific expression pattern. In living organisms their activity is a delicate balance of expression, targeting, zymogen activation, inhibition by protein inhibitors and degradation. The specificity of their substrate binding sites, small-molecule inhibitor repertoire and crystal structures are providing new tools for research and development. Their unique reactive-site properties have made it possible to confine the targets simply by the use of appropriate reactive groups. The epoxysuccinyls still dominate the field, but now nitriles seem to be the most appropriate "warhead". The view of cysteine cathepsins as lysosomal proteases is changing as there is now clear evidence of their localization in other cellular compartments. Besides being involved in protein turnover, they build an important part of the endosomal antigen presentation. Together with the growing number of non-endosomal roles of cysteine cathepsins is growing also the knowledge of their involvement in diseases such as cancer and rheumatoid arthritis, among others. Finally, cysteine cathepsins are important regulators and signaling molecules of an unimaginable number of biological processes. The current challenge is to identify their endogenous substrates, in order to gain an insight into the mechanisms of substrate degradation and processing. In this review, some of the remarkable advances that have taken place in the past decade are presented. This article is part of a Special Issue entitled: Proteolysis 50 years after the discovery of lysosome.

Makaleyi görüntüle
The use of and search for drugs and dietary supplements derived from plants have accelerated in recent years. Ethnopharmacologists, botanists, microbiologists, and natural-products chemists are combing the Earth for phytochemicals and "leads" which could be developed for treatment of infectious diseases. While 25 to 50% of current pharmaceuticals are derived from plants, none are used as antimicrobials. Traditional healers have long used plants to prevent or cure infectious conditions; Western medicine is trying to duplicate their successes. Plants are rich in a wide variety of secondary metabolites, such as tannins, terpenoids, alkaloids, and flavonoids, which have been found in vitro to have antimicrobial properties. This review attempts to summarize the current status of botanical screening efforts, as well as in vivo studies of their effectiveness and toxicity. The structure and antimicrobial properties of phytochemicals are also addressed. Since many of these compounds are currently available as unregulated botanical preparations and their use by the public is increasing rapidly, clinicians need to consider the consequences of patients self-medicating with these preparations.

Makaleyi görüntüle

Kaynaklar ve Görseller

« Carica Dodecaphylla Carica Pennata »